Compounds > tetrabenazine
Page last updated: 2024-08-17

tetrabenazine and selegiline

tetrabenazine has been researched along with selegiline in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Zaleska, B1
Knoll, B; Knoll, J; Miklya, I; Shimazu, S; Yasusa, T; Yoneda, F1
Miklya, I2
Baqi, Y; Correa, M; Khan, B; Lee, CA; Makriyannis, A; Müller, CE; Nowak, V; Nunes, EJ; Pandit, S; Randall, PA; Salamone, JD; Shah, P; Vemuri, VK; Yohn, SE1
Correa, M; Dortche, K; Podurgiel, SJ; Salamone, JD; Yohn, SE1
Contreras-Mora, H; Correa, M; Rowland, MA; Salamone, JD; Yohn, SE1

Reviews

2 review(s) available for tetrabenazine and selegiline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
    Neurologia i neurochirurgia polska, 1980, Volume: 14, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride

1980

Other Studies

7 other study(ies) available for tetrabenazine and selegiline

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged.
    Life sciences, 2002, Sep-13, Volume: 71, Issue:17

    Topics: Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Avoidance Learning; Benzofurans; Brain; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Injections, Subcutaneous; Norepinephrine; Rats; Selegiline; Serotonin; Tetrabenazine

2002
[A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2008, Volume: 10, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Brain Stem; Catecholamines; Clorgyline; Indans; Learning; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Pargyline; Rats; Selegiline; Tetrabenazine

2008
Essential difference between the pharmacological spectrum of (-)-deprenyl and rasagiline.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:3

    Topics: Animals; Indans; Learning Disabilities; Levodopa; Male; Neurons; Parkinson Disease; Rats; Rats, Wistar; Selegiline; Tetrabenazine

2014
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Animals; Antidepressive Agents; Benzazepines; Benzophenones; Bupropion; Cannabinoid Receptor Antagonists; Choice Behavior; Depression; Dopamine Antagonists; Drug Evaluation, Preclinical; Feeding Behavior; Male; Nitrophenols; Pyrazoles; Rats, Sprague-Dawley; Salicylamides; Selegiline; Tetrabenazine; Tolcapone; Vesicular Monoamine Transport Proteins; Xanthines

2014
The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
    Behavioural brain research, 2016, Feb-01, Volume: 298, Issue:Pt B

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Jaw; Male; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Random Allocation; Rats, Sprague-Dawley; Selegiline; Tetrabenazine; Tremor; Vesicular Monoamine Transport Proteins

2016
Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 166

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eating; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motivation; Rats; Selegiline; Tetrabenazine; Treatment Outcome

2018